#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Enteritis Pemphigoid Extraskeletal ossification Follicular lymphoma stage I Rhabdomyosarcoma recurrent Lung adenocarcinoma Acute respiratory distress syndrome Arginase deficiency Gaucher's disease type I Depression Alveolar rhabdomyosarcoma Arteriovenous malformation Langerhans' cell histiocytosis Hepatitis D Acquired C1 inhibitor deficiency More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Diagnostics Glycogen storage disease type V – Life with Disease Primary hyperoxaluria – Basic Information Phenylketonuria – Life with Disease Turner’s syndrome – Basic Information Haemophilia B with anti factor IX – Diagnostics Atypical haemolytic uraemic syndrome – Basic Information Cystic fibrosis lung – Basic Information Erdheim-Chester disease – Trials in Disease Atypical haemolytic uraemic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betula Alba Pollen Extract Dorocubicel Atl001 Sodium Valproate Etifoxine Hydrochloride Memantine Hydrochloride Sodium Chloride Solution 0.9% Calcium Polystyrene Sulfonate Eftrenonacog Alfa Retifanlimab Ketamine Hydrochloride Ticagrelor Keto-Valine Calcium GSK5733584 Glepaglutide Promazine Hydrochloride Cerebrolysin Concentrate Somapacitan Vimseltinib Tramadol Hydrochloride More therapies…

    Learn about Your Condition

    Fatty acid oxidation disorder Hodgkin's disease recurrent Pharyngeal cancer stage I Osteochondrodysplasia Pharyngeal cancer stage III Cognitive disorder Brain cancer metastatic Oropharyngeal cancer recurrent Psychological trauma Gastrectomy Mastocytosis Incontinence Oesophageal disorder Urticaria Portal hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of GD2-CAR T Cells, Cyclophosphamide, and Fludarabine for Children with High-Risk or Relapsed Neuroblastoma and Other GD2+ Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • AUTOLOGOUS T CELLS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR AGAINST GD2, EX-VIVO EXPANDED
    • RIMIDUCID
    • Fludarabine Phosphate
    Italy

  • Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Study on the Effects of Sirolimus Cream for Patients with Port Wine Stains

    Recruiting

    2 1 1
    Investigated Diseases:
    • Naevus flammeus
    Investigated Drugs:
    • Sirolimus
    Spain

  • Study of Mesenchymal Stromal Cells Treatment for Patients with Traumatic Brain Injury: A Safety and Effectiveness Trial

    Recruiting

    2 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    Italy

  • Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

    Recruiting

    3 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Spain

  • Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

    Recruiting

    3 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • TIFCEMALIMAB
    • Toripalimab
    Belgium France Germany Italy The Netherlands Poland +2
Previous Page
1 … 251 252 253 254 255 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!